Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...

At least a dozen large drugmakers are set to roll out copies of Novo Nordisk’s blockbuster weight-loss drugs in India, crashing prices as soon as the patent expires on Friday. Natco Pharma plans to ...

Come March 20, when the patent for Semaglutide expires, the Indian market is expected to see the launch of generic drugs from at least seven pharma companies, at costs ranging from one-third to ...

Indian firms such as Ajanta Pharma, Dr Reddy's Laboratories, Lupin, Mankind Pharma and Sun Pharmaceuticals are poised to fulfil domestic demand for weight-loss drugs with more affordable generic ...

A newly-formed Canadian pharmaceutical company is vying to break into the market with a generic version of one of the most well-known prescription drugs in the world: Ozempic. “You could say we’re ...

Access to affordable medicines remains one of the biggest challenges in healthcare systems worldwide, especially in low- and middle-income countries. In India, where a significant portion of medical ...

Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countries Weight-loss jabs such as Wegovy could be made for just $3 a month, according to new ...

For months, President Donald Trump and his aides touted efforts to lower prescription drug prices for Americans. Now consumers can check prices at the recently launched website TrumpRx.gov. "This is a ...

Muriel, from the Auxiliary of Social Life, works at the home of Mr. T, who has multiple sclerosis, in Pas de Calais, France, on June 11, 2023. (Astier / BSIP via AFP) (CN) — For people living with ...

WASHINGTON--(BUSINESS WIRE)--Tom Neely, chairman of Oxford Pharmaceuticals, testified Wednesday before the U.S. Senate Special Committee on Aging, urging Congress to recognize generic pharmaceuticals ...